10
Participants
Start Date
February 28, 2011
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
Milnacipran
Patients will receive a titrated dose of milnacipran increasing to a maximum of 100mg a day over the 12 week study period. Dosing will be based on a fixed schedule that will be monitored using a side effect profile.
Placebo
Subjects will be given placebo tablets at dosing corresponding to the fixed schedule between 12.5mg and 100mg.
Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx
Collaborators (1)
Forest Laboratories
INDUSTRY
Montefiore Medical Center
OTHER